相关实验视频
Updated: Jun 20, 2026

06:48
An Orthotopic Murine Model of Human Prostate Cancer Metastasis
Published on: September 18, 2013
35.1K
基因签名用于预测前列腺癌转移,使用初级瘤表达特征
medRxiv : the preprint server for health sciences
|September 10, 2024
概括
一种新的基因标记,Meta-Score,可以预测前列腺癌 (PCa) 患者的转移. 这个工具可以识别高风险个体,改善局部性前列腺癌的早期检测和患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 生物标志物发现发现
背景情况:
- 前列腺癌 (PCa) 是癌症死亡的主要原因,转移显著恶化预后.
- 目前的方法难以准确预测局部PCa中的转移风险,突出显示了对新生物标志物的需求.
- 识别患有转移高风险的患者对于及时干预和改善生存结果至关重要.
研究的目的:
- 开发和验证一种基因表达特征,用于预测局部性前列腺癌 (PCa) 的转移.
- 确定一个强大的生物标志物,可以根据PCa患者的转移风险准确地分层PCa患者.
- 评估与患者存活率相关的开发签名的预后效用.
主要方法:
- 利用1000名PCa患者的回顾性原发性瘤基因表达特征的元分析工作流来识别预测基因.
- 开发了一种45个基因的签名,Meta-Score,并在239名PCa患者的独立队列中验证了其预测性能.
- 采用了统计方法,包括赫奇斯的g效应大小,费舍尔的综合概率测试,本雅米尼-霍赫伯格校正和多变量考克斯比例危险模型.
主要成果:
- 开发的Meta-Score基因签名在预测转移方面表现强,在验证队列中达到0.72的AUC.
- 甲基评分显示出显著的预后效用,将更高的风险得分与更差的无转移和无进展生存率联系在一起.
- 即使在多变量分析中对格里森得分进行调整后,签名的预后值仍然显著.
结论:
- 主要瘤转录特征的Meta-Score是评估局部性前列腺癌 (PCa) 转移风险的宝贵工具.
- 这种基因特征可以帮助识别患有转移和不良生存率高的患者.
- 需要在大型前性研究中进一步验证,以确定Meta-Score作为PCa风险分层的临床标准.
相关概念视频
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer-Critical Genes I: Proto-oncogenes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...

